Strains – a word I use expressly – of music weasel through the wall of our segregated domain. Wailing men from decades long ...
A phase 2 trial of Sanofi's experimental therapy for alpha-1 antitrypsin deficiency (AATD) has raised the hope of an ...
Safety Monitoring Committee (SMC) recommended initiation of Part B of the peanut allergy trialFunding secured for follow-on tree (Fagales) pollen program MY010 ...
CD Projekt are taking a new approach to internal documentation with The Witcher 4 and Cyberpunk 2, after major screw-ups ...
Mabylon reports positive phase Ia results in MY006 peanut allergy trial and initiates phase Ib patient part of the study: Switzerland Wednesday, May 20, 2026, 13:00 Hrs [IST] Maby ...
Stardust from ancient supernova explosions has been discovered in Antarctic ice, offering clues about the Solar System’s path ...
Aulos Bioscience, a clinical-stage immuno-oncology company developing an immune-activating antibody therapeutic designed by leveraging an AI platform, today announced positive Phase 2 data from its ...
After weeks of blindsides, betrayals, twists and double eliminations, Aubry Bracco has been crowned the Sole Survivor of ...
Solar panels stop working when the sky goes dark. That simple fact has pushed energy researchers into a stubborn problem: how ...
3d
Exelixis, Inc. (EXEL) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
RBC Capital Markets Global Healthcare Conference 2026 May 19, 2026 9:00 AM EDTCompany ParticipantsAndrew Peters - Senior ...
Detailed price information for Celldex Therapeutics (CLDX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results